Itzykson, R., Santini, V., Thepot, S., Ades, L., Chaffaut, C., Giagounidis, A., . . . Fenaux, P. (2023). Decitabine versus hydroxyurea for advanced proliferative chronic myelomonocytic leukemia: Results of a randomized phase III trial within the EMSCO Network. Journal of clinical oncology, 41(10), . https://doi.org/10.1200/JCO.22.00437
Chicago-Zitierstil (17. Ausg.)Itzykson, Raphael, et al. "Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network." Journal of Clinical Oncology 41, no. 10 (2023). https://doi.org/10.1200/JCO.22.00437.
MLA-Zitierstil (9. Ausg.)Itzykson, Raphael, et al. "Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network." Journal of Clinical Oncology, vol. 41, no. 10, 2023, https://doi.org/10.1200/JCO.22.00437.